PATENT CLAIM ANALYSIS

Application Number: 15889714
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "373000"]

Abstract:
Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

Claim (Index 10):
The method of  claim 1 , wherein the therapeutically effective amount of dexpramipexole, or a pharmaceutically acceptable salt thereof, is administered as an initial dosing regimen followed by a maintenance dosing regimen.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14912015', '15675912', '15461131', '15181526', '13966229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8408156983221472
- 35 USC 102 Novelty (BERT): 0.5968712826338635
- Combined Prediction Score: 0.8164212567533189
- Mean Citation Score: 483.247764
- Max Citation Score: 514.1058
- Similarity Product: 481.7273880242586

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test